mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
KIN001-135 |
GDSC1000 |
pan-cancer |
AAC |
0.021 |
0.7 |
mRNA |
ATRA |
FIMM |
pan-cancer |
AAC |
0.063 |
0.7 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.7 |
mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.7 |